Have fibrates or fish oils affected the pharmacokinetics or pharmacodynamics of Waylivra (volanesorsen sodium) in clinical studies?

In clinical studies, fibrates and fish oils had no impact on Waylivra (volanesorsen sodium) pharmacokinetics or pharmacodynamics, and no interaction-related adverse events were reported, but these findings rely on limited data and no clinical drug interaction studies have been conducted.